using mounjaro for weight loss
Mounjaro, is known generically as tirzepatide.
It is a prescription only medication (POM) and is primarily approved for managing type 2 diabetes in adults to improve blood sugar control when combined with diet and exercise. Additionally, Mounjaro has shown significant efficacy in promoting weight loss, leading to its approval for weight management in individuals with obesity or overweight conditions accompanied by weight-related health issues.
Risks and Considerations
Common side effects include:
- nausea
- vomiting
- diarrhea
- decreased appetite
- constipation
- abdominal discomfort
Serious but less common risks involve pancreatitis, kidney problems, and gastrointestinal disorders.
Due to potential risks, Mounjaro carries a boxed warning about thyroid C-cell tumors and is contraindicated in individuals with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2.
Mounjaro is not suitable for individuals with type 1 diabetes and has not been established as safe for use in pediatric patients. Its use should be under the guidance of a qualified healthcare professional, with regular monitoring to manage any adverse effects and assess treatment efficacy.